Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

SRx Health Solutions (SRXH) Shares Outstanding (Diluted Average) (2016 - 2025)

SRx Health Solutions' Shares Outstanding (Diluted Average) history spans 14 years, with the latest figure at $21.1 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) fell 4.4% year-over-year to $21.1 million; the TTM value through Sep 2025 reached $21.1 million, down 4.4%, while the annual FY2025 figure was $21.1 million, N/A changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $21.1 million in Q3 2025 per SRXH's latest filing, up from $19.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $29.4 million in Q3 2022 to a low of $667114.0 in Q4 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $14.7 million, with a median of $21.1 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): crashed 97.64% in 2023, then soared 3244.19% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $21.9 million in 2021, then crashed by 96.95% to $667114.0 in 2022, then increased by 5.71% to $705185.0 in 2023, then skyrocketed by 3244.19% to $23.6 million in 2024, then fell by 10.5% to $21.1 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Shares Outstanding (Diluted Average) are $21.1 million (Q3 2025), $19.3 million (Q2 2025), and $2.6 million (Q1 2025).